Industry-Related News

  • Students' Plan to Tackle Epileptic Seizures

    By Richard Merritt Seizures, the often frightening and historically misunderstood outward manifestations of epilepsy, have long challenged physicians and struck fear in patients. Although there are drugs on the market to control seizures, many patients receive little benefit. But there may now be a reason to hope for some of these patients. Though the technology is still in its infancy, a new approach to controlling seizures championed by five Duke University graduate students four from the ...
  • Duke optical spinoff company wins Frost & Sullivan North America Award for Excellence in Research

    Bioptigen, a spinoff company co-founded by Duke biomedical engineer Joseph Izatt, has won the Frost & Sullivan 2007 North American Optical Coherence Tomography Excellence in Research Award. Bioptigen was singled out for its work in spectral-domain optical coherence tomography (SD-OCT) for ophthalmology. "This recognition is validation of our vision for the current and future potential of SD-OCT," said Izatt, professor of biomedical engineering and opthamology, and Chief Technology Officer at Bioptigen. "Our emphasis looking forward is ...
  • Startup Advanced Liquid Logic Receives Frost & Sullivan's Entrepreneurial Company of the Year Award

    Advanced Liquid Logic, which is developing miniscule fluidic technology that can turn silicon chips into labs, is consulting firm Frost & Sullivan's choice for its 2007 Entrepreneurial Company of the Year award. The rising startup company, founded by former Duke engineering graduate students Michael Pollack and Vamsee Pamula, is a spin-out from Duke University's Pratt School of Engineering. The microfluidic technology originated in the laboratoy of the Pratt School's Richard Fair, a professor of electrical and ...
  • Clinical Activity for Celsion's Thermodox® Reported

    Note: Article adapted from a news release issued by Celsion. Columbia, MD Early results from a Phase I clinical study of ThermoDox for treating patients with recurrent breast cancer on the chest wall revealed that after only two cycles of a low-dose, six-cycle regimen, six patients showed early signs of clinically meaningful activity, according to a release issued by Celsion Corporation. One patient had a complete response in the treated area, two patients had ...
  • MBright

    Dean Kristina M. Johnson and Duke electrical and computer engineering doctoral graduate Sangrok Lee founded MBright, a next-generation digital display technology company after winning $50,000 in startup funding from the Duke Startup Challenge in 2004. MBright utilizes liquid crystal on silicon microdisplays including VLSI design.
  • NDI Medical

    Formed in 2002, NDI Medical develops, manufactures, commercializes and markets neurostimulation products. Their experienced team of business executives, engineers and regulatory professionals have built a successful, growing, implantable neurostimulation medical device company located in Cleveland, one of the world's leading centers for neurostimulation research. Founder Warren Grill is an associate professor in Duke's Biomedical Engineering Department. URL: www.ndimedical.com/index.htm
  • Memscept

    Photonics and ultrasound engineering researchers from Duke's Pratt School of Engineering and George Washington University created a spinoff company in 2003 to market a novel optical scanner miniaturized enough to be inserted into the body, where its light beams could someday detect abnormalities hidden in the walls of the colon, bladder or esophagus. The experimental device is called an "electrostatic micromachine scanning mirror for optical coherence tomography." Memscept founders include Jason Zara, an assistant professor ...
  • Illuminus

    Illuminus is a Duke spinoff company developing technology to measure the removal of breast tumors during breast conserving surgery. An estimated 125,000 women diagnosed with early stage breast cancer receive breast conserving surgery each year. The project manager, Dr. Nimmi Ramanujam, an internationally recognized researcher in biomedical engineering, will provide the technical direction for the venture. She is a tenured faculty member at Duke University. She was the winner of the MIT Technology Review TR100 ...
  • Advanced Liquid Logic

    Advanced Liquid Logic develops products that leverage the Company's unique droplet-based liquid handling technology for high quality, reliable, rapid, and cost effective results in a diverse range of diagnostic and other applications. Digital microfluidics is a lab-on-a-chip approach based on direct, programmable micromanipulation of small volume droplets using electrical fields. Digital microfluidics enables complex, multi-step liquid handling protocols to be flexibly, scalably, and cost effectively implemented. Invented at Duke University. URL: http://www.liquid-logic.com/index.html
  • Signal Innovations Group, Inc.

    Signal Innovations Group, Inc. (SIG) is a Research Triangle Park, NC based company that is pioneering new data modeling methods and cutting-edge algorithm design for pattern recognition and decision systems. These technologies have enabled our customers to understand and exploit sensor data in new ways that break old performance barriers. SIG has developed analytic tools to perform customized decision-systems design and enhanced data understanding. SIG is a Duke University spinoff company, founded by electrical and ...
  • Humacyte

    Humacyte is a vascular tissue engineering company pioneering the production of replacement blood vessels on demand with a patient's own cells. Humacyte's patented technology will focus specifically on producing small diameter grafts for patients suffering from coronary artery disease (CAD) or peripheral artery disease (PAD). Founder and former Duke bioengineering professor Laura Niklason is conducting preclinical tests now and hopes to enter clinical trials within the next few years. Humacyte is actively working to bridge ...
  • Bioptigen

    Bioptigen has pioneered a new class of in vivo optical imaging systems for biomedical applications. These systems enable real-time non-invasive imaging of internal tissue microstructure, advancing critical applications in drug development, genetics research, tissue engineering, and medical vision. Bioptigen is a spin-out of the Duke University Biomedical Engineering Department. Bioptigen was incorporated in North Carolina in August, 2004, to commercialize technologies originating in the laboratories of Professor Joseph Izatt. Bioptigen technology is based ...
  • Centice

    Centice designs and manufactures molecular spectroscopy optical sensors that are used by our partners in general purpose and application-specific products. Centice sensors are based on patent-pending computational sensor technology exclusively licensed from Duke University, where the technology was first developed. Computational sensors combine multiplexing optical designs with electronics and proprietary mathematical algorithms, to achieve both extreme sensitivity and uncompromised resolution a breakthrough that had previously been unattainable. URL: http://www.centice.com
  • Ford Encourages Motorsports Innovation

    Ford Motor Co. provided financial support to the Duke University Motorsports club. This is a team of undergraduate students that design, fabricate and race an open-wheeled Formula SAE Series car in the Formula SAE competition in Detroit, Mich., as well as in several autocrosses across the state of North Carolina. The team also participates in community outreach programs. Ford support pays for supplies, insurance and travel to the national competition.
  • Questions about this page? Contact:

    Deborah Hill, Director of Communications, 415 Teer Engineering Building, 919-660-8403, dahill@duke.edu